GF Fund Management’s ResMed RMD Stock Holding History

GF Fund Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$889K	Hold	4,021	–	–	0.01%	189
2026 Q2	$784K	Buy	4,021 +42	+1%	+$8.7K	0.01%	196
2026 Q1	$893K	Hold	3,979	–	–	0.01%	196
2025 Q4	$958K	Sell	3,979 -73	-2%	-$18.7K	0.02%	198
2025 Q3	$1.11M	Buy	4,052 +446	+12%	+$122K	0.02%	193
2025 Q2	$930K	Sell	3,606 -26	-0.7%	-$6.2K	0.02%	214
2025 Q1	$813K	Hold	3,632	–	–	0.02%	216
2024 Q4	$831K	Buy	+3,632	New	+$875K	0.02%	206

Other funds holding RMD

Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return

Washington Trust Advisors Wellesley, Massachusetts $1.4B AUM 26.88% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

UniSuper Management Melbourne, Victoria, Australia $20.4B AUM 33.79% 1-Year Est. Return

Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return

NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return

GF Fund Management's RMD Position: Q3 2026 in Review

GF Fund Management held its ResMed (RMD) position steady in Q3 2026 at 4,021 shares worth $889K. The position accounts for 0.01% of the portfolio, ranked #189.

GF Fund Management first reported a position in RMD in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.11M in Q3 2025. 199 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

GF Fund Management held 4,021 shares of ResMed worth $889K as of Q3 2026.
GF Fund Management left its ResMed share count unchanged in Q3 2026.
ResMed made up 0.01% of GF Fund Management's portfolio in Q3 2026, its #189 holding.
GF Fund Management first reported a position in ResMed in Q4 2024 and has held it in 8 quarters since.
GF Fund Management's ResMed position peaked at $1.11M in Q3 2025.
199 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.